MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04866cam a2200445 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
on1259294854 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220316143706.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
210629t20212021nyu b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2021026643 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
OCLCO |
| -- |
OCLCF |
| -- |
TOH |
| -- |
OCO |
| -- |
NTG |
| -- |
ILC |
| -- |
YDX |
| -- |
OCLCO |
| -- |
OBE |
| -- |
NFG |
| 019 ## - |
|---|
| -- |
1269403071 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781250273161 |
| Qualifying information |
hardcover |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1250273161 |
| Qualifying information |
hardcover |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)1259294854 |
| Canceled/invalid control number |
(OCoLC)1269403071 |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 043 ## - GEOGRAPHIC AREA CODE |
|---|
| Geographic area code |
n-us--- |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
338.7616 |
| Item number |
H232 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
NFGA |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hampton, Ryan, |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Unsettled : |
| Remainder of title |
how the Purdue Pharma bankruptcy failed the victims of the American overdose crisis / |
| Statement of responsibility, etc |
Ryan Hampton, ; with Claire Rudy Foster and Hillel Aron. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
St. Martin's Press, |
| Date of production, publication, distribution, manufacture |
2021. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
|---|
| Date of production, publication, distribution, manufacture |
©2021 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 322 pages ; |
| Dimensions |
22 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content Type Term |
text |
| Content Type Code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media Type Term |
unmediated |
| Media Type Code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier Type Term |
volume |
| Carrier Type Code |
nc |
| Source |
rdacarrier |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Preface -- Introduction -- Billions served -- A sleeping giant -- The blizzard was coming -- Flesh and blood -- Unchecked power -- The death curve -- Last month's tuna roll -- Lawyers, meds, and money -- Toothless -- "A legal fiction" -- The breaking point -- Conclusion : the way out -- Afterword. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
In September 2019, Purdue Pharma--the maker of OxyContin and a company controlled by the infamous billionaire Sackler family--filed for bankruptcy to protect itself from 2,600 lawsuits for its role in fueling the U.S. overdose crisis. Author and activist Ryan Hampton served as co-chair of the official creditors committee that acted as a watchdog during the process, one of only four victims appointed among representatives of big insurance companies, hospitals, and pharmacies. He entered the case believing that exposing the Sacklers and mobilizing against Purdue would be enough to right the scales of justice. But he soon learned that behind closed doors, justice had plenty of other competition--and it came with a hefty price tag. Unsettled is the inside story of Purdue's excruciating Chapter 11 bankruptcy proceedings, the company's eventual restructuring, and the Sackler family's evasion of any true accountability. It's also the untold story of how a group of determined ordinary people tried to see justice done against the odds--and in the face of brutal opposition from powerful institutions and even government representatives. Although America was envisioned as an equitable place, where the vulnerable are protected from the greed of the powerful, the corporate-bankruptcy process betrays those values. In its heart of hearts, this system is built to shield the ultra-wealthy, exploit loopholes for political power, promote gross wealth inequality, and allow companies such as Purdue Pharma to run amok. The real story of the Purdue bankruptcy wasn't that the billion-dollar corporation was a villain, a serial federal offender. No matter what the media said, Purdue didn't do this alone. They were aided and abetted by the very systems and institutions that were supposed to protect Americans. Even on-your-side elected officials worked against Purdue's victims--maintaining the status quo at all costs. Americans deserve to know exactly who is responsible for failing to protect people over profits--and what a human life is worth to corporations, billionaires, and lawmakers. Unsettled is what happened behind closed doors--the story of a sick, broken system that destroyed millions of lives and let the Sacklers off almost scot-free. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
September 2019: Purdue Pharma, the maker of OxyContin and a company controlled by the infamous billionaire Sackler family, filed for bankruptcy to protect itself from lawsuits for its role in fueling the U.S. overdose crisis. Hampton served as co-chair of the official creditors committee that acted as a watchdog during the process, and entered the case believing that exposing the Sacklers and mobilizing against Purdue would be enough to right the scales of justice. He tells the inside story of Purdue's excruciating Chapter 11 bankruptcy proceedings, the company's eventual restructuring, and the Sackler family's evasion of any true accountability. He shows how the system is built to shield the ultra-wealthy, exploit loopholes for political power, promote gross wealth inequality, and allow companies such as Purdue Pharma to run amok. -- adapted from jacket |
| 610 20 - SUBJECT ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Purdue Pharma L.P. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical industry |
| General subdivision |
Moral and ethical aspects |
| Geographic subdivision |
United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Opioid abuse |
| Geographic subdivision |
United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Bankruptcy |
| General subdivision |
Moral and ethical aspects. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Foster, Claire Rudy, |
| Relator term |
author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Aron, Hillel, |
| Relator term |
author. |
| 994 ## - |
|---|
| -- |
C0 |
| -- |
NFG |
